Skip to Content


In the US, Somatropin (somatropin systemic) is a member of the drug class growth hormones and is used to treat Adult Human Growth Hormone Deficiency, AIDS Related Wasting, Burns - Nitrogen Retention, Cachexia, Growth Retardation - Chronic Renal Failure, Hypopituitarism, Idiopathic Short Stature, Noonan's Syndrome, Pediatric Growth Hormone Deficiency, Prader-Willi Syndrome, Short Bowel Syndrome, Short Stature for Age and Turner's Syndrome.

US matches:

UK matches:

Ingredient matches for Somatropin


Somatropin (BAN, USAN) is also known as Somatropine (Rec.INN)


BANBritish Approved Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.